“We will probably do better with low volume, by focusing on niche APIs than with high volume ones,” he said, adding that a lot of other chemical processes in the...
GenWorks said it aims to double revenues in FY23 and the funding will be leveraged to cover working capital needs, relevant M&A to invest in manufacturing partnerships, and expansion in...
Vikram Kelkar, MD, Hexagon Nutrition explains the widespread problem of Malnutrition and Food Fortification being one of the best solutions to combat the problem. This is inline to achieve UN...
A pharmaceutical formulations and API manufacturing company. Established in 2006, Globela is an established ISO, FDCA – India and WHO cGMP accredited formulations manufacturing company with multiple therapeutic areas including...
Somerset Indus Capital Partners has picked up a minority stake in Gujarat-based Globela Pharma Pvt Ltd, marking the healthcare-focused private equity firm's first bet in the pharmaceutical space in India.
A quick synopsis of issues and areas entrepreneurs and organizations need to keep in mind to prosper in the new, tech-enabled terrain of healthcare. Healthcare has transformed itself post-Covid. Technology...
Earlier this month, the debut fund of healthcare-focused private equity firm Somerset Indus Capital Partners made its first partial exit via an initial public offering (IPO) from Krsnaa Diagnostics. Previously,...
Amid all the challenges, technology-enabled solutions will be key to accessible healthcare for all as it offers opportunities to streamline processing and improving overall patient experience..
